Journal of International Oncology ›› 2012, Vol. 39 ›› Issue (10): 755-758.

Previous Articles     Next Articles

Dendritic cells and tumor immunotherapy

 LI  Wen-Xiang, NIU  Wei-Xin   

  1. Department of General Surgery, Zhongshan Hospital Affiliated to Fudan University, Shanghai 200032, China
  • Online:2012-10-31 Published:2012-10-31
  • Contact: NIU Wei-xin, E-mail:niu.weixin@zs-hospital.sh.cn E-mail:niu.weixin@zs-hospital.sh.cn

Abstract: In vivo, dendritic cells(DCs)are the most powerful antigenpresenting cells (APCs). DCs based neoplasm immunotherapy has recently become the focus of research. DCs can be used not only as separate cell vaccine to mediate antitumor immunity, but can also be combined with cytokines, immune cells, and other methods in tumor immunotherapy. In animal models and clinical trials, DCbased immunotherapy as well as other tumor immunotherapy strategies have gained more significant progress.

Key words: Dendritic cells, Neoplasms, Immunity